Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hyman

Showing results (331-340 of 401) with videos related to

Pageof 41
Sort By:
Cancer Cell|November 6, 2018
Widespread Selection for Oncogenic Mutant Allele Imbalance in CancerCraig M Bielski, Mark T A Donoghue, Mayur Gadiya, et al.
Annals of Surgical Oncology|May 5, 2018
Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric CancerElke J A H van Beek, Jonathan M Hernandez, Debra A Goldman, et al.
Urologic Oncology|June 4, 2018
Commentary on "DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma."M Y Teo, R M Bambury, E C Zabor, et al.
Gynecologic Oncology|November 24, 2019
Clinical outcomes of patients with POLE mutated endometrioid endometrial cancerMarina Stasenko, Irina Tunnage, Charles W Ashley, et al.
Blood|August 24, 2014
Recurrent RAS and PIK3CA mutations in Erdheim-Chester diseaseJean-François Emile, Eli L Diamond, Zofia Hélias-Rodzewicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2017
DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial CarcinomaMin Yuen Teo, Richard M Bambury, Emily C Zabor, et al.
JCO Precision Oncology|September 11, 2020
Real-World Outcomes of an Automated Physician Support System for Genome-Driven OncologyJessica J Tao, Michael H Eubank, Alison M Schram, et al.
ESMO Open|August 3, 2022
Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumorsE Borazanci, A M Schram, E Garralda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2018
Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for InterventionMaeve A Lowery, Ryan Ptashkin, Emmet Jordan, et al.
Plos One|February 26, 2013
Feedback-based, system-level properties of vertebrate-microbial interactionsAriel L Rivas, Mark D Jankowski, Renata Piccinini, et al.
Pageof 41

Showing results (331-340 of 401) with videos related to

Sort By:
Pageof 41
Cancer Cell|November 6, 2018
Widespread Selection for Oncogenic Mutant Allele Imbalance in CancerCraig M Bielski, Mark T A Donoghue, Mayur Gadiya, et al.
Annals of Surgical Oncology|May 5, 2018
Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric CancerElke J A H van Beek, Jonathan M Hernandez, Debra A Goldman, et al.
Urologic Oncology|June 4, 2018
Commentary on "DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma."M Y Teo, R M Bambury, E C Zabor, et al.
Gynecologic Oncology|November 24, 2019
Clinical outcomes of patients with POLE mutated endometrioid endometrial cancerMarina Stasenko, Irina Tunnage, Charles W Ashley, et al.
Blood|August 24, 2014
Recurrent RAS and PIK3CA mutations in Erdheim-Chester diseaseJean-François Emile, Eli L Diamond, Zofia Hélias-Rodzewicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2017
DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial CarcinomaMin Yuen Teo, Richard M Bambury, Emily C Zabor, et al.
JCO Precision Oncology|September 11, 2020
Real-World Outcomes of an Automated Physician Support System for Genome-Driven OncologyJessica J Tao, Michael H Eubank, Alison M Schram, et al.
ESMO Open|August 3, 2022
Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumorsE Borazanci, A M Schram, E Garralda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2018
Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for InterventionMaeve A Lowery, Ryan Ptashkin, Emmet Jordan, et al.
Plos One|February 26, 2013
Feedback-based, system-level properties of vertebrate-microbial interactionsAriel L Rivas, Mark D Jankowski, Renata Piccinini, et al.
Pageof 41